Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹44.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 33.47 per cent from ₹66.96 crore. This corresponds to a year-on-year *(YoY) decline of 33.73 per cent.
PBDT
PBDT stands at ₹194.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.22 per cent from ₹196.47 crore. This corresponds to a year-on-year *(YoY) growth of 32.78 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.08 per cent from ₹194.97 crore. This represents a 172.65 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | 1.21% | -4.27% | -6.23% | 8.14% | 14.45% | 90.09% |
| Biocon | -1.68% | -2.55% | -7.30% | 1.83% | -5.42% | -1.01% |
| Abbott India | 0.47% | 0.20% | -3.61% | -6.55% | -15.38% | 4.89% |
| Glenmark Pharma. | -1.26% | -1.00% | -1.95% | 8.75% | -7.93% | 40.57% |
| Glaxosmi. Pharma | -3.32% | -0.78% | -6.22% | -13.96% | -25.17% | 12.05% |
| Ipca Labs. | -1.53% | -1.69% | 1.58% | 12.68% | -1.38% | 1.41% |
| Anthem Bioscienc | 0.70% | -0.93% | -6.84% | -16.87% | -19.35% | -16.58% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru